CK Life Sciences Int’l., (Holdings) Inc. (stock code: 0775) is listed on the Stock Exchange of Hong Kong. Bearing the mission of improving the quality of life, CK Life Sciences is engaged in the business of research and development, manufacturing, commercialisation, marketing, sale of, and investment in, products and assets which fall into three core categories - nutraceuticals, pharmaceuticals and agriculture-related. CK Life Sciences is a member of the CK Hutchison Group.
| Website | https://www.ck-lifesciences.com/eng/ |
| Revenue | $679.6 million |
| Employees | 86 (51 on RocketReach) |
| Fax | +852 2126 1211 |
| Industry | Biotechnology Research, Business Services General, Business Services |
| Web Rank | 8 Million |
| Keywords | Life Sciences, Biotechnology, Life Sciences Research, Healthcare, Pharmaceutical Research, Drug Development, Biopharmaceutical, Drug Discovery, Health Technology, Pharmaceutical Manufacturing, Healthcare Innovation, Medical Research, Clinical Trials, Precision Medicine, Medical Devices, Genetic Engineering, Regenerative Medicine, Pharmaceutical Sales |
| Competitors | Roche, Pfizer, Boehringer Ingelheim, AstraZeneca, Teva Pharmaceuticals, Novartis, Baxter International Inc., Merck AH, 田辺三菱製薬(株), Lilly India +42 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies |
Looking for a particular CK Life Sciences employee's phone or email?
The CK Life Sciences annual revenue was $679.6 million in 2026.
Melvin Toh is the Vice President and Chief Scientific Officer of CK Life Sciences.
51 people are employed at CK Life Sciences.
The NAICS codes for CK Life Sciences are [5417, 541, 54, 541713, 54171].
The SIC codes for CK Life Sciences are [873, 87].